We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Kits Enable Rapid Labeling of Proteins and Other Macromolecules

By LabMedica International staff writers
Posted on 17 Nov 2014
Biotech or other life science researchers who prepare their own bioconjugated proteins, antibodies, or macromolecules will benefit from a new series of rapid labeling kits.

Innova Biosciences (Cambridge, United Kingdom), launched new antibody and protein labeling kits within its Lightning-Link Rapid range. More...
These kits enable researchers to label primary antibodies or other proteins in about 20 minutes.

This range of kits include those for labeling molecules with high sensitivity Atto and Cy dyes as well as a rapid biotin conjugation kit. Boasting a reaction with an exceptionally short incubation time, the biotinylation kit yields conjugates with performance characteristics identical to, or better than, those prepared with laborious multistep conjugation procedures. Furthermore, the method does not require desalting or dialysis steps. Thus, Lightning-Link Rapid technology can be used to label small quantities of material with nearly 100% recovery.

Dr. Nick Gee, CEO of Innova, said: "The launch of the Lightning-Link kits completes the development of our Rapid conjugation range, and follows on from the success of the original kits, which had a much longer reaction time. This latest product introduction underlines Lightning-Link as one of the world’s leading bioconjugation technologies, offering easy-to-use labeling that provides excellent results with minimal hands on time and 100% yield.”

Related Links:

Innova Biosciences



Gold Member
Neonatal Heel Incision Device
Tenderfoot
Online QC Software
Acusera 24•7
New
HPV Test
Allplex HPV28 Detection
New
Automated Urinalysis Solution
UN-9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.